Armistice Capital »

Imunon shares owned by Armistice Capital

Quarter-by-quarter ownership of Imunon (IMNN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Imunon

Tip: Access up to 7 years of quarterly data

All positions including Imunon held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Imunon by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 348k 2.94

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Imunon

Armistice Capital
Vanguard Capital Management
Vanguard Group
Riverview Capital Advisers
Geode Capital Management
Vanguard Fiduciary Trust
Hrt Financial
BlackRock
Wells Fargo & Company
Morgan Stanley
SBI Securities
UBS Group
Tower Research Capital
Group One Trading
Federation des caisses Desjardins du Quebec

View all funds holding Imunon